Godavari Drugs (BOM:530317) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Godavari Drugs's Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Godavari Drugs's Revenue for the three months ended in Dec. 2023 was ₹431 Mil. Therefore, Godavari Drugs's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Godavari Drugs's current FCF Yield % is 5.37%.

The historical rank and industry rank for Godavari Drugs's FCF Margin % or its related term are showing as below:

BOM:530317' s FCF Margin % Range Over the Past 10 Years
Min: -11.04 Med: 0.02 Max: 3.71
Current: 2.52

During the past 13 years, the highest FCF Margin % of Godavari Drugs was 3.71%. The lowest was -11.04%. And the median was 0.02%.

BOM:530317's FCF Margin % is ranked better than
57.74% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.12 vs BOM:530317: 2.52

Godavari Drugs FCF Margin % Historical Data

The historical data trend for Godavari Drugs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs FCF Margin % Chart

Godavari Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

1.35

-0.67

-0.28

3.71

2.46

Godavari Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Godavari Drugs's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Godavari Drugs's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's FCF Margin % falls into.

Godavari Drugs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Godavari Drugs's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	39.204	/	1596.248
	=	2.46 %

Godavari Drugs's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	431.105
	=	0.00 %

Godavari Drugs FCF Margin % Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Godavari Drugs (BOM:530317) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003

Website

https://www.godavaridrugs.com

Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines